Koesten Hirschmann & Crabtree’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521K Buy
+434
New +$443K 0.22% 21
2025
Q2
Sell
-40
Closed -$33K 349
2025
Q1
$33K Hold
40
0.02% 101
2024
Q4
$30.9K Buy
+40
New +$33.1K 0.02% 102

Other funds holding LLY

Koesten Hirschmann & Crabtree's LLY Position: Q2 2026 in Review

Koesten Hirschmann & Crabtree opened a new position in Eli Lilly (LLY) in Q2 2026: 434 shares worth $521K. The stake represents 0.22% of the portfolio and ranks #21 among its holdings. This is a return to the name: Koesten Hirschmann & Crabtree previously reported a position in LLY as recently as Q1 2025.

Koesten Hirschmann & Crabtree first reported a position in LLY in Q4 2024 and has held it in 3 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Koesten Hirschmann & Crabtree held 434 shares of Eli Lilly worth $521K as of Q2 2026.
  • Eli Lilly was a new Koesten Hirschmann & Crabtree position in Q2 2026.
  • Eli Lilly made up 0.22% of Koesten Hirschmann & Crabtree's portfolio in Q2 2026, its #21 holding.
  • Koesten Hirschmann & Crabtree first reported a position in Eli Lilly in Q4 2024 and has held it in 3 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q2 2026, filed 20 Jul 2026.